The ISCT Annual Meeting, hosted by the International Society for Cell & Gene Therapy, is one of the largest global conferences dedicated to advancing cell and gene therapy research and clinical translation. The event brings together thousands of scientists, clinicians, industry professionals, and regulators from more than 60 countries to share cutting-edge research, discuss emerging technologies, and address key challenges in developing and delivering advanced therapies.

Featuring hundreds of speakers, scientific presentations, and abstract sessions across a four-day program, the meeting focuses on accelerating innovation in areas such as gene editing, cell-based therapies, and biomanufacturing while fostering collaboration, networking, and partnerships that help translate scientific discoveries into real-world treatments for patients.

Date: May 6-9, 2026
Location: Convention Centre Dublin, Dublin, Ireland
Booth: #2204

JOIN US!

From autologous to allogeneic and iPSC-derived cell therapies, we provide flexible collaboration, tailored solutions, and proven operational excellence. Our white-glove case management delivers end-to-end professional supply chain coordination, helping teams bring transformative therapies to patients sooner. Come meet our cell therapy team at booth #2204 to discuss how we can accelerate your path forward.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS!

Date/Time: Thursday, May 7, 2026 at 13:30-13:45
Location: Theatre B, Liffey Floor (Level 1)
Title: GMP iPSC Lines and Manipulations Workflows: from Lessons Learned to Partnerships Easing Translation to Clinic and Patient Cures.
Speaker: Frederic Cedrone, Vice President Corporate Innovation, ӣ����Ƶ

NETWORKING EVENTS!

2026 ISCT Global Industry Networking Reception Sponsor

Date/Time: Thursday, May 7, 2026 at 19:00 – 22:30 GMT (local time)
Location: The Guinness Storehouse *transportation provided
Address: St. James’s Gate, Dublin 8, D08 VF8H, Ireland
This prestigious annual reception is the largest CGT translational networking event, bringing together academic visionaries, global regulatory experts, and industry decision-makers.

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

The Cell & Gene Meeting on the Mediterranean (“Meeting on the Med”) is a leading international conference focused on the advanced therapies sector, particularly cell and gene therapies. Organized by the Alliance for Regenerative Medicine, the event brings together biotechnology and pharmaceutical executives, researchers, investors, regulators, and other industry stakeholders from Europe and around the world to discuss the development and commercialization of advanced therapy medicinal products (ATMPs). The conference features expert-led panels, company presentations, and extensive networking and one-on-one partnering meetings. Key topics include regulatory issues, market access, manufacturing challenges, financing strategies, and emerging innovations in areas such as gene therapy, CAR-T, and regenerative medicine, with dozens of companies presenting their latest progress and partnerships.

Date: April 28-30, 2026
Location: Rome Cavalieri, Rome, Italy

JOIN US!

We deliver fully integrated solutions across plasmids, viral vectors, autologous and allogeneic cell therapies, and iPSCs. Meet our Cell & Gene Therapy team to explore how our phase-appropriate approach can advance your program with confidence.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaking Engagement 1
Speaker: Philip Wills, Chief Commercial Officer, ӣ����Ƶ
Date/Time: Wednesday, April 29, 2026, 1:30 – 1:45 PM
Title: Enabling Patient Impact Through Strategic CDMO Partnerships

Speaking Engagement 2
Speaker: Frederic Cedrone, Vice President Corporate Innovation, ӣ����Ƶ
Date/Time: Tuesday, April 28, 2026, 5:15 – 6 PM
Title: AI-Driven Acceleration in Cell and Gene Therapy: From Discover to Delivery

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

COG New England is a two-day meeting in the Boston area that brings together senior clinical trial decision-makers from New England and the broader East Coast to hear from industry, regulatory, and academic thought leaders while building connections through networking. It positions itself as a premier gathering for the region’s clinical trial sector, pairing multi-stream agenda content with trusted solution providers.

Date: April 28-29, 2026
Location: Burlington, Massachusetts (Boston area)
Booth: #15

JOIN US!

We’re heading to COG New England this April – a regional forum bringing together senior clinical trial leaders across New England and the East Coast.
Join ӣ����Ƶ at booth #15 in Burlington, MA, where we’ll be sharing perspectives on how sponsors are navigating today’s clinical supply challenges and what’s next as trials grow more complex.

Connect with the ӣ����Ƶ team – schedule a meeting.

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

Excipient World explores cutting-edge scientific developments, formulation and technology advancements, quality production and the safe use of excipients, as well as regulatory mandates to better address the ever-changing global marketplace. The event brings buyers and suppliers together to explore new product innovations and potential collaborations.

Date: May 4-6, 2026
Location: Nashville, Tennessee
Event Website:

JOIN US!

Discover how ӣ����Ƶ formulation expertise, advanced oral delivery technologies and integrated development and manufacturing capabilities can help you overcome complex drug development challenges. Schedule a meeting with us to see how we can support your next breakthrough.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Karunakar Sukuru (Karu), R.Ph., Ph.D., Global Vice President-Pharma Product Development & Head- Scientific Advisory
Date: Tuesday, May 5, 2026 at 8:00am
Title: Excipients: The Unsung Heroes in Addressing Bioavailability and Quality Challenges
Location: Ryman Hall Stage 1

Excipients, often overshadowed by active pharmaceutical ingredients, are indispensable in the formulation of high-quality drug products. They play a pivotal role in overcoming the barriers posed by poorly soluble and poorly permeable drugs, significantly improving bioavailability and therapeutic efficacy. Despite their critical contributions from solubilization and stabilization to controlled release, the importance of excipients remains under-recognized in the broader pharmaceutical landscape. This presentation will delve into the multifaceted functions of excipients, emphasizing their impact on drug delivery systems and patient outcomes.

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

TIDES USA is a leading scientific and industry forum that brings together global experts in oligonucleotide, peptide, mRNA, genome editing and drug delivery to share cutting-edge research, development strategies and commercialization insights. The event features multiple concurrent tracks, workshops, poster sessions and networking opportunities designed to accelerate next-generation therapeutics from discovery through manufacturing and market launch.

Date: May 11-14, 2026
Location: Boston, Massachusetts
Event Website:

JOIN US!

Discover how ӣ����Ƶ is advancing oral drug development and delivery of macromolecules with modified release technology, bioavailability enhancement and scientific innovation. Schedule a meeting with our experts to see how we can support your next breakthrough.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Amruta Mhashilkar, Associate Director, Formulation & Process Development
Date: Wednesday, May 13, 2026 at 1:00pm
Title: Overcoming Barriers to Oral Delivery of Macromolecules Through Innovative Technologies

Oral delivery of peptides and proteins remains constrained by gastrointestinal instability, enzymatic degradation, and limited permeability. Emerging technologies—including advanced lipid-based formulations, delayed-release softgels, and buccal or sublingual systems—offer strategies to protect molecules, enable targeted intestinal release, as well as lymphatic delivery. This presentation will examine how these approaches can improve exposure and unlock clinically meaningful oral delivery of macromolecules with data.

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

The CRBE Summit East brings together senior drug development innovators to explore the latest advances in controlled release systems, bioavailability enhancement strategies and continuous manufacturing technologies for pharmaceutical products. Attendees benefit from technical talks, panel discussions, networking opportunities and exposure to emerging formulation and delivery solutions across the industry.

Date: May 12-13, 2026
Location: Princeton, New Jersey

JOIN US!

Discover how ӣ����Ƶ is advancing oral drug development and delivery of macromolecules with modified release technology, bioavailability enhancement and scientific innovation. Schedule a meeting with our experts to see how we can support your next breakthrough.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Karunakar Sukuru (Karu), R.Ph., Ph.D., Global Vice President-Pharma Product Development & Head- Scientific Advisory
Date: Tuesday, May 12, 2026
Title: Innovating Oral Drug Delivery: Enabling Small and Macromolecule Therapies

The oral administration of macromolecules such as peptides and proteins continues to be limited by harsh gastrointestinal conditions, rapid enzymatic degradation, and poor membrane permeability. Novel delivery technologies—such as sophisticated lipid-based systems, delayed-release softgel platforms, and buccal or sublingual approaches—are emerging to overcome these barriers. By protecting sensitive compounds, directing site-specific release in the intestine, and leveraging lymphatic transport
pathways, these solutions aim to enhance systemic exposure. This presentation will highlight the scientific rationale and data demonstrating how these innovations are advancing the clinical feasibility of oral macromolecule delivery. The current state of macromolecule delivery and recent advances in this space will be discussed.

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

The PEGS (Protein & Antibody Engineering) Boston Summit is a leading annual conference that brings together scientists, biotech and pharma leaders, and researchers to share advances in biologics, protein engineering, and antibody research. This event features hundreds of presentations, training courses, and networking opportunities covering topics such as antibody and protein design, immunotherapy, bispecifics, AI/ML for biologics, and analytical characterization. It’s widely regarded as a key forum for learning about cutting-edge science, practical R&D strategies, and emerging technologies shaping the future of biologic drug development.

Date: May 11-15, 2026
Location: Omni Boston Hotel at the Seaport, Boston, Massachusetts
Booth: 806

JOIN US!

Join ӣ����Ƶ at PEGS US in Boston this May, where our experts will be on hand to discuss how our integrated biologics development and manufacturing capabilities help accelerate complex protein programs from discovery to commercialization.

Meet us at our booth throughout the conference and attend our featured presentation to learn how we’re advancing higher yield, higher quality protein production workflows.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Valeria Guzman, Associate Principal Scientist, Process Development, Downstream
Date/Time: Friday, May 15^th, 2026, at 10:00 a.m. | Maximizing Protein Production Workflows
Title: From Complexity to Consistency: High‑Throughput Screening Strategies for Scalable Multispecific Antibody Development

Speaker: Amruta Mhashilkar, Associate Director, Formulation & Process Development
Date/Time: Thursday, May 14^th, 2026 at 3:40pm
Title: Breaking the Injection Barrier: Overcoming Challenges to Oral Delivery of Peptides

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

The Pulmonary Drug Delivery Workshop (PDD) is an interactive forum that brings together researchers and innovators in inhalation and pulmonary drug delivery to share insights, discuss recent advances, and foster collaboration. It emphasizes informal discussions, practical sessions, and networking opportunities across the field.

Date: April 15-17, 2026
Location: Dublin, Ireland

JOIN US!

Join us at the Pulmonary Drug Delivery Workshop to explore ӣ����Ƶ’s end‑to‑end expertise in inhaled and nasal development. Our team supports DPIs, nasal sprays, and spray‑dried powders from early feasibility through clinic—helping programs move faster with less risk.

Complete the form to schedule a meeting with our experts.

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

The Global Clinical Supplies Group (GCSG) North American events consist of a series of professional conferences and networking gatherings focused on clinical supply chain topics, bringing together industry experts for interactive workshops, presentations, and peer-to-peer collaboration. These events include recurring U.S. conferences in various cities and specialized meetups that explore current hot topics, best practices, and innovations in clinical supplies management.

Date: April 26-29, 2026
Location: San Diego, California
Booth: #35

JOIN US!

We’re looking forward to connecting with clinical supply leaders at GCSG 2026 US Conference in San Diego in April.

Stop by booth #35 or arrange to meet with ӣ����Ƶ to explore how sponsors are navigating today’s clinical supply challenges through flexible, experience-driven models. We’ll share perspectives on building resilient supply strategies from early development through late-phase execution.

SPEAKING ENGAGEMENTS

Speaker: Erica Reed, Senior Clinical Supplies Manager
Date/Time: 27^th April 2026, 10:15 AM EST – 27 April 2026 (10:15 am – 11:15 am)
Title: Clarifying Roles and Responsibilities through RACIs (B)

Speaker: Erica Reed, Senior Clinical Supplies Manager
Date/Time: 29^th April 2026, 10:45 AM EST – 29 April 2026 (10:45 am – 11:45 am)
Title: Clarifying Roles and Responsibilities through RACIs (B)

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™

This PBSS event is a comprehensive professional workshop designed to guide scientists and industry professionals through the essential components of preparing a high-quality IND (Investigational New Drug) filing for small molecule therapeutics, including preclinical study requirements and regulatory strategies. It brings together experienced speakers to share best practices across safety, DMPK, CMC, clinical planning, and agency interactions to support efficient drug development and compliance.

Date: April 17, 2026
Location: San Francisco, California

JOIN US!

Come meet us at PBSS on April 17 to explore how ӣ����Ƶ’s integrated macromolecule and small molecule capabilities can accelerate your development programs. Learn how our end‑to‑end expertise helps de‑risk, optimize, and advance molecules from early phase to clinic and beyond.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Nathan Bennette, Director, Scientific and Technical Advisory
Date/Time: 17^th April 2026
Title: Formulation Challenges: Know What Problem You’re Trying to Solve

NETWORKING EVENTS!

Don’t miss to connect with our experts at the PBSS lunch reception sponsored by ӣ����Ƶ on April 17 to learn more about our macromolecule and small molecule capabilities.

ABOUT CATALENT

ӣ����Ƶ, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ӣ����Ƶ helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ӣ����Ƶ provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ӣ����Ƶ tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ӣ����Ƶ supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™